TGF-β is also involved in modulating immune response against cancer cells: while DC stimulate CD8+ differentiation in co-culture with PC cells, TGF-β blockade improves antigen specific response and decreases T cells apoptosis; as a consequence, DC vaccination in combination with TGF-β blockade results in increased DFS in murine tumor models [104]. The gene discussed is CD8A; the disease is cancer.